Phoenix – June 12, 2017 – Axolotl Biologix, Inc., a biotech company that focuses on research and technology to enhance regenerative medicine, announced today that it will be exhibiting at the BIO Conference. The conference will be held June 19th-23rd at the San Diego Convention Center in San Diego, California. Axolotl Biologix will be exhibiting in the Arizona Pavilion at Booth 5519.
Axolotl Biologix’ CEO Bob Maguire stated, “We are excited to be a part of this event with over 17,000 attendees from around the world. We have dozens of meetings scheduled and are hoping to gain partnerships and opportunities to acquire more intellectual property.”
About Axolotl Biologix, Inc.:
Axolotl Biologix, Inc. is a biotech company that develops and manufactures human cell and tissue products for orthopedic, wound care, podiatric, and aesthetic markets. The Company’s currently has two products to market. The first is it’s AxoBioFluid®, which is an amniotic allograft cryopreserved liquid that advances soft tissue repair, replacement, and reconstruction. The second is it’s AxoBioMembrane, which is an amniotic allograft membrane used for wound care and surgical applications. The Company’s vision is to be an innovative and global leader in regenerative medicine through research, technology, and clinical application.
For more information, please visit Axolotl Biologix’ website at www.axobio.com
SOURCE Axolotl Biologix, Inc.
602-334-1298 ext. 1
About Axolotl Biologix:
Our Mission Axolotl Biologix is focused on enabling the body’s own cells and tissues to improve the quality of life through research, technology, and enterprise. Our Vision Axolotl Biologix is committed to being an innovative and global leader of regenerative medicine through research, technology, and clinical application.